Blocking the IL-1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV-accelerated chronic rejection
Open Access
- 17 June 2020
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 21 (1), 44-59
- https://doi.org/10.1111/ajt.16149
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 AI116633, 2T32 AI007472, F31 1F311AI145193‐01, OD P51 OD011092)
- Oregon Health and Science University
This publication has 44 references indexed in Scilit:
- Cytomegalovirus CC Chemokine Promotes Immune Cell MigrationJournal of Virology, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- RNA-SeQC: RNA-seq metrics for quality control and process optimizationBioinformatics, 2012
- LabKey Server: An open source platform for scientific data integration, analysis and collaborationBMC Bioinformatics, 2011
- Cytomegalovirus Latency Promotes Cardiac Lymphoid Neogenesis and Accelerated Allograft Rejection in CMV Naïve RecipientsAmerican Journal of Transplantation, 2010
- Measuring dementia carers' unmet need for services - an exploratory mixed method studyBMC Health Services Research, 2010
- Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantationJournal of Inflammation, 2010
- Immunobiology of Human Cytomegalovirus: from Bench to BedsideClinical Microbiology Reviews, 2009
- Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejectionThe Journal of Experimental Medicine, 2008